Screener
Fulgent Genetics, Inc. FLGT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding as of March 31, 2026, and December 31, 2025 | — | — |
| Additional paid-in capital | 540,141 | 574,520 |
| Accumulated other comprehensive income | 4,536 | 7,512 |
| Retained earnings | 505,128 | 529,954 |
| Total Fulgent stockholders’ equity | 1,049,809 | 1,111,989 |
| Noncontrolling interest | (5,655) | (5,274) |
| Total stockholders’ equity | 1,044,154 | 1,106,715 |
| Total liabilities and stockholders’ equity | $1,156,369 | $1,213,525 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s retained earnings?
- Fulgent Genetics, Inc. (FLGT) reported retained earnings of $505.13M in Q1 2026.
- How has Fulgent Genetics, Inc.'s retained earnings changed year-over-year?
- Fulgent Genetics, Inc.'s retained earnings decreased by 12.7% year-over-year, from $578.94M to $505.13M.
- What is the long-term trend for Fulgent Genetics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s retained earnings has grown at a 28.6% compound annual growth rate (CAGR), from $150.88M to $529.95M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Fulgent Genetics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude